dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide has been researched along with calcitriol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuizumi, T; Inoue, H; Kawagishi, S; Tsujisawa, T; Uchiyama, C | 1 |
1 other study(ies) available for dibenz(b,f)(1,4)oxazepine-10(11h)-carboxylic acid, 8-chloro-, 2-acetylhydrazide and calcitriol
| Article | Year |
|---|---|
SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures.
Topics: Animals; Bone Marrow Cells; Calcitriol; Cell Culture Techniques; Cell Differentiation; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Mice; Mice, Inbred ICR; Osteoblasts; Osteoclasts; Prostaglandin Antagonists; Rats; Rats, Wistar | 1999 |